Gene · 3039
NIH grants1,435
NIH grants whose papers are about the gene, through NIH's grant-paper links.
381 to 400 of 1,435
Download this page as JSON| Grant | Title | HBA1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA241762 | Linking insertional mutagenesis and cell function to improve CAR T cell therapy | 1 | 2023 |
| R01DK121671 | Coordinate regulation of erythroid and macrophage lineages in development by EKLF/KLF1 | 1 | 2023 |
| R01ES014639 | Mechanisms of Vascular Toxicity from Inhaled Toxicants | 1 | 2023 |
| R01GM116961 | Breakthrough Molecular Dynamics Research via an Anton2 Supercomputer | 1 | 2023 |
| R01GM121806 | Mechanisms of gene silencing induced by long noncoding RNAs | 1 | 2023 |
| R01GM130738 | Investigating the co-transcriptional impact of genetic variation on gene regulation and disease | 1 | 2023 |
| R01GM133961 | Burn induces hypermetabolism via browning of the white adipose tissue | 1 | 2023 |
| R01HD098387 | Epigenetic control of the human X chromosome | 1 | 2023 |
| R01HG010898 | Identification of Genetic and Molecular Bases of Derived Phenotypes in Primate Brain Development | 1 | 2023 |
| R01HL127342 | Role of Sphingolipid pathways in the pathobiology of PAH | 1 | 2023 |
| R01HL142825 | Characterizing pleiotropy in cardiometabolic phenotypes among diverse populations | 1 | 2023 |
| R01HL149683 | Semiparametric Analysis of Big Censored Data | 1 | 2023 |
| R01HL149685 | Structural basis for cardioprotective HDL | 1 | 2023 |
| R01HL149714 | Interactions between the ADORA2b/Sphk1axis and the AE1-Hb switch in red blood cell aging in vivo and in vitro | 1 | 2023 |
| R01HL149870 | The Role of PRDM16 in Cardiac Development and Cardiomyopathy | 1 | 2023 |
| R01HL150669 | Rectifying splicing mutations in blood disorders by gene editing | 1 | 2023 |
| R01HL151777 | Embryonic natural killer cell development and function | 1 | 2023 |
| R01HL154385 | Structural and Nucleotide Variation as Genomic Risks for Venous Thrombosis: TOPMED and INVENT Collaboration | 1 | 2023 |
| R01LM010098 | Bioinformatics Strategies for Genome Wide Association Studies | 1 | 2023 |
| R01NS106612 | NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3039/grants?page=20